-
Mashup Score: 57
By working through a series of realistic case scenarios, you will experience how to manage a variety of AML presentations over time. As you make decisions, you will receive expert corrective mentoring from virtual colleagues to help you recognize optimal decision-making patterns.
Source: education.nccn.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Paper: A Qualitative Study Comparing the Patient and Provider Experience in an Academic Blood Disorder Center - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 901. Health Services and Quality Improvement – Non-Malignant Conditions: Poster II Hematology Disease Topics & Pathways: Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI) Hunter Tolison, BS 1 *, Cassandra Duarte, MD 2, Glen Peterson, DNP 3 *, Grace N Bosma, MS 4 *, Diana Abbott, PhD 1, Gemlyn George, MD 1, Daniel Pollyea 1, Craig T. Jordan, PhD 5 and Maria L Amaya, MD, PhD 6 1 University of Colorado, Aurora, CO 2 University
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
RT @MariaAmaya_27: 3. Understanding and comparing pt and provider experience in our center https://t.co/bjUxMcw3Vh by MDPhD student @hunert…
-
-
Mashup Score: 5Paper: Results from a Phase (Ph) 1 Clinical Study of the All-Oral Regimen of CC-486 and Venetoclax for Relapsed and Refractory Acute Myeloid Leukemia - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Pos ter II Hematology Disease Topics & Pathways: Research, clinical trials, Clinical Research Maria L Amaya, MD, PhD 1, Christine M. McMahon 2, Marc Schwartz, MD 1 *, Jonathan A Gutman, MD 3, Connor Sohalski 3 *, Jennifer Tobin, PharmD 3 *, Austin E Gillen, PhD 2 *, Anagha Inguva Sheth, BSc 3, Brett M Stevens, PhD, BS 3 *, Clayton Smith, MD 3, Craig
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
RT @MariaAmaya_27: Check out the abstract of our completed Ph 1 of the all oral regimen (ven/oral aza) in AML! https://t.co/KS4UO1CyqZ @Dan…
-
-
Mashup Score: 2
By working through a series of realistic case scenarios, you will experience how to manage a variety of AML presentations over time. As you make decisions, you will receive expert corrective mentoring from virtual colleagues to help you recognize optimal decision-making patterns.
Source: education.nccn.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Check out this really cool #AML interactive Simulator Project that myself and @jaltmanmd helped @NCCN develop. It's good for CME credit and pretty fun! AI meets AML... https://t.co/ObUq7xP2ZZ
-
-
Mashup Score: 2Sign the Petition - 9 month(s) ago
Eliminate ABIMs MOC requirement
Source: www.change.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Eliminate ABIMs MOC requirement - Sign the Petition! https://t.co/bFO0MCKvLs via @Change
-
-
Mashup Score: 1CU ASPIRE Program Awardees - 11 month(s) ago
The School of Medicine’s Program to Advance Physician Scientists and Translational Research is pleased to announce its 2023 CU ASPIRE Program awardees. This year’s awards have been made to four teams led by Drs. Brianne Bettcher, Craig Jordan, Traci Lyons, and Carmen (Kika) Sucharov. These teams include faculty from seven departments across the School of Medicine. The CU ASPIRE Program is…
Source: medschool.cuanschutz.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CUDeptMedicine: Kudos to the 2023 CU ASPIRE Program Awardees from the Department of Medicine! Learn more: https://t.co/qETMNfZA0L Craig…
-
-
Mashup Score: 5Clinical Trials Leadership | Division of Hematology - 1 year(s) ago
Hematology Clinical Trials Unit Leadership The Hematology Clinical Trials Unit is led by Daniel Pollyea, MD, Derek Schatz, and Natalie Pfenning. Professor, Division of HematologyI believe in finding the best, most cutting edge…
Source: medschool.cuanschutz.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CUHematology: Last week: Hematology Clinical Trials Leadership https://t.co/BJcrzgO3ZX Add this week: Division Leadership 🎉🍾🎉 Congratu…
-
-
Mashup Score: 1Home - Denver ASH Review - 1 year(s) ago
Welcome 2023 Join us! Friday, February 25th Experts in lymphomas, plasma cell disorders, myeloproliferative neoplasms, acute myeloid leukemia, myelodysplastic syndrome, and coagulation disorders will provide exciting updates from ASH 2022 with a focus on the latest treatment advances relevant to your clinical practice. The day will include presentations, case reviews, and interactive question and…
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @CUHematology: https://t.co/gxeq26EUEe February 2023 (!!) Right-Around-the-Corner (!!) Registration is open for in-person @CUAnschutz OR…
-
-
Mashup Score: 3Post-Award Grant Specialist - 2 year(s) ago
Click the link provided to see the complete job description.
Source: cu.taleo.netCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CUHematology: Our Division is seeking more amazing team members! Please refer and RT. https://t.co/Z0MFcaiBjF https://t.co/B9lsg0W5l8…
-
-
Mashup Score: 1Congreso Clas - 2 year(s) ago
page-description
Source: webinar.tecnoxia.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @zapata_nidia: https://t.co/JwUSCkQYBE https://t.co/F6WtSt1N0Q
-
Check out this really cool #AML interactive Simulator Project that myself and @jaltmanmd helped @NCCN develop. It's good for CME credit and pretty fun! AI meets AML... https://t.co/ObUq7xP2ZZ